Chronic Obstructive Pulmonary Disease
Showing NaN - NaN of 44
COPD Trial in Worldwide (Benralizumab, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Benralizumab
- Placebo
-
Montgomery, Alabama
- +400 more
Jan 11, 2023
COPD Trial in Worldwide (Itepekimab SAR440340, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Itepekimab SAR440340
- Placebo
-
Palm Springs, California
- +231 more
Dec 19, 2022
COPD Trial in Worldwide (Ensifentrine, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Ensifentrine
- Placebo
-
Alabaster, Alabama
- +140 more
Nov 30, 2022
COPD Trial in Worldwide (Astegolimab, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Astegolimab
- Placebo
-
Andalusia, Alabama
- +170 more
Aug 4, 2022
COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Dupilumab SAR231893
- +4 more
-
Cullman, Alabama
- +334 more
Jun 14, 2022
COPD, COPD Trial in United States (CHF 5259, Placebo, Tiotropium Bromide 18 µg Inhalation Capsule)
Completed
- COPD
- Chronic Obstructive Pulmonary Disease
- CHF 5259
- +2 more
-
Birmingham, Alabama
- +111 more
May 20, 2021
COPD Trial in San Diego (Portable Oxygen Cylinder, Mobi)
Completed
- Chronic Obstructive Pulmonary Disease
- Portable Oxygen Cylinder
- Mobi
-
San Diego, CaliforniaSleepData
May 24, 2021
Copd, COPD, Hypercapnia Trial in San Diego (High-intensity non-invasive ventilation)
Terminated
- Copd
- +4 more
- High-intensity non-invasive ventilation
-
San Diego, CaliforniaUniversity of California San Diego
Aug 24, 2020
Obstructive Sleep Apnea, COPD, Overlap Syndrome Trial in San Diego (Bi-level positive airway pressure (BPAP), Nocturnal oxygen)
Completed
- Obstructive Sleep Apnea
- +2 more
- Bi-level positive airway pressure (BPAP)
- Nocturnal oxygen
-
San Diego, CaliforniaUniversity of California, San Diego
Jul 13, 2020
COPD, COPD, Moderate to Very Severe COPD Trial in Canada, United States (Aclidinium Bromide, Placebo)
Completed
- COPD
- +2 more
- Aclidinium Bromide
- Placebo
-
Birmingham, Alabama
- +467 more
Nov 8, 2018
COPD Trial in Worldwide (Aclidinium bromide 400 µg/Formoterol Fumarate 12 µg (AB/FF 400/12 µg), Aclidinium bromide 400 µg (AB
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium bromide 400 μg/Formoterol Fumarate 12 μg (AB/FF 400/12 μg)
- +5 more
-
Gulf Shores, Alabama
- +162 more
Nov 7, 2018
Data of Adipose Stem Cells to Treat Chronic Obstructive
Unknown status
- Chronic Obstructive Pulmonary Disease
-
San Diego, CaliforniaStemGenex
Aug 28, 2018
COPD Trial in United States (QVA149, Umeclidinium/vilanterol, Placebo (umeclidinium/vilanterol ))
Completed
- Chronic Obstructive Pulmonary Disease
- QVA149
- +3 more
-
Anaheim, California
- +52 more
Mar 2, 2018
COPD, COPD Trial in United States (SUN-101 50 mcg BID eFlow (CS) nebulizer, SUN-101 25 mcg BID eFlow (CS) nebulizer, Placebo
Completed
- COPD
- Chronic Obstructive Pulmonary Disease
- SUN-101 50 mcg BID eFlow (CS) nebulizer
- +2 more
-
Andalusia, Alabama
- +44 more
Feb 13, 2018
COPD Trial in United States (MP-376, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- MP-376
- Placebo
-
Haleyville, Alabama
- +38 more
Jan 17, 2018
COPD Trial in United States (Aclidinium Bromide/Formoterol Fumarate, Formoterol Fumarate)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium Bromide/Formoterol Fumarate
- Formoterol Fumarate
-
Birmingham, Alabama
- +136 more
Apr 3, 2017
COPD Trial in United States (Supplemental oxygen therapy)
Completed
- Chronic Obstructive Pulmonary Disease
- Supplemental oxygen therapy
-
Birmingham, Alabama
- +38 more
Apr 3, 2017
COPD Trial in Worldwide (Aclidinium bromide/formoterol Fixed-Dose Combination (FDC), Aclidinium bromide, Formoterol Fumarate)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)
- +3 more
-
Anniston, Alabama
- +207 more
Mar 9, 2017
COPD Trial in Canada, United States (Aclidinium Bromide 200 µg, Aclidinium Bromide 400 µg)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium Bromide 200 µg
- Aclidinium Bromide 400 µg
-
Birmingham, Alabama
- +112 more
Mar 9, 2017
COPD Trial in Worldwide (carmoterol (CHF 4226), salmeterol, )
Completed
- Chronic Obstructive Pulmonary Disease
- carmoterol (CHF 4226)
- +2 more
-
Jonesboro, Arkansas
- +49 more
Apr 7, 2017
COPD Trial in Australia, New Zealand, United States (GFF MDI, GP MDI, FF MDI)
Completed
- Chronic Obstructive Pulmonary Disease
- GFF MDI
- +4 more
-
Andalusia, Alabama
- +139 more
Feb 7, 2017
COPD Trial in Worldwide (Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium Bromide/Formoterol Fumarate
- +3 more
-
Anniston, Alabama
- +221 more
Feb 2, 2017
COPD Trial in Australia, New Zealand, United States (PT005 MDI, PT001 MDI, PT003 MDI)
Completed
- Chronic Obstructive Pulmonary Disease
- PT005 MDI
- +3 more
-
Glendale, Arizona
- +19 more
Dec 7, 2016
COPD Trial in Canada, United States (Aclidinium bromide, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium bromide
- Placebo
-
Birmingham, Alabama
- +111 more
Nov 30, 2016
COPD Trial in Canada, United States (Aclidinium bromide)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium bromide
-
Birmingham, Alabama
- +82 more
Nov 16, 2016